The Benefit/Risk Ratio
A Handbook for the Rational Use of Potentially Hazardous Drugs
Published on 24. July 1998
400 pages
978-1-040-20456-6 (ISBN)
Description
The use of drugs as remedies for various types of diseases has a long tradition; however, it has only been recently recognized that the value of any given compound must be evaluated in light of its benefit to risk ratio. When prescribing drugs, physicians must look at the big picture of the drug's benefits in relation to its side effects and possib
More details
Language
English
Place of publication
London
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
College/higher education
File size
8,12 MB
ISBN-13
978-1-040-20456-6 (9781040204566)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Hans C. Korting | M. Schafer-Korting
The Benefit/Risk Ratio
A Handbook for the Rational Use of Potentially Hazardous Drugs
Book
06/2020
1st Edition
CRC Press
€81.70
Shipment within 15-20 days
Hans C. Korting | M. Schafer-Korting
The Benefit/Risk Ratio
A Handbook for the Rational Use of Potentially Hazardous Drugs
Book
07/1998
1st Edition
CRC Press
€217.50
Shipment within 15-20 days
Persons
Korting, Hans C. | Schafer-Korting, M.
Content
The Role and Analysis of Benefit and Risk in the Development of New Drugs. Prediction of the Benefit/Risk Ratio from In Vitro Data. Evaluation of Therapeutic Benefits and Toxicological Risks Using Structure-Activity Relational Expert Systems. Improving the Therapeutic Index Through Unusual Routes of Application: Intra-Arterial Treatment of Liver Metastases. Establishing the Benefit/Risk Ration with Combination Drugs. Improving the Therapeutic Index of Antineoplastic Agents through Additional Drugs. Antihypertensive Agents. Diueretics. Anti-Diabetic Drugs. Anticonvulsant Drugs and Drugs for Parkinson's Disease. Antihistamines and Antiserotonins. Cytokines and Immunomodulators. Non-Opioid Analgesics and Anti-Inflammatory Agents. Toxicity Profile of Liposomal Anthacyclines. Antibacterial Agents. Antiviral Agents. Drugs Used in Reproductive Endocrinology. Nicotine Preparations in Smoking. Systemic Drugs for Skin Diseases. Topical Liposome Drugs. Topical Glucocorticoids. Index.
